Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era
Abstract
Purpose:
Radical prostatectomy, external beam radiotherapy and brachytherapy are accepted treatments for localized prostate cancer. However, it is unknown if survival differences exist among treatments. We analyzed the survival of patients treated with these modalities according to contemporary standards.
Materials and Methods:
A total of 10,429 consecutive patients with localized prostate cancer treated with radical prostatectomy (6,485), external beam radiotherapy (2,264) or brachytherapy (1,680) were identified. Multivariable regression analyses were used to model the disease (biopsy grade, clinical stage, prostate specific antigen) and patient specific (age, ethnicity, comorbidity) parameters for overall survival and prostate cancer specific mortality. Propensity score analysis was used to adjust for differences in observed background characteristics.
Results:
The adjusted 10-year overall survival after radical prostatectomy, external beam radiotherapy and brachytherapy was 88.9%, 82.6% and 81.7%, respectively. Adjusted 10-year prostate cancer specific mortality was 1.8%, 2.9% and 2.3%, respectively. Using propensity score analysis, external beam radiotherapy was associated with decreased overall survival (HR 1.6, 95% CI 1.4–1.9, p <0.001) and increased prostate cancer specific mortality (HR 1.5, 95% CI 1.0–2.3, p = 0.041) compared to radical prostatectomy. Brachytherapy was associated with decreased overall survival (HR 1.7, 95% CI 1.4–2.1, p <0.001) but not prostate cancer specific mortality (HR 1.3, 95% CI 0.7–2.4, p = 0.5) compared to radical prostatectomy.
Conclusions:
After adjusting for major confounders, radical prostatectomy was associated with a small but statistically significant improvement in overall and cancer specific survival. These survival differences may arise from an imbalance of confounders, differences in treatment related mortality and/or improved cancer control when radical prostatectomy is performed as initial therapy.
References
- 1 : Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol1982; 128: 502. Link, Google Scholar
- 2 : A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol2006; 36: 789. Google Scholar
- 3 : An update on randomized clinical trials in localized and locoregional prostate cancer. Urol Oncol2005; 23: 280. Google Scholar
- 4 : Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA1998; 280: 969. Google Scholar
- 5 : Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Urology2007; 70: 283. Google Scholar
- 6 : An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer2002; 95: 2126. Google Scholar
- 7 : Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol2006; 24: 3973. Google Scholar
- 8 : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys2006; 65: 965. Google Scholar
- 9 : Natural history of progression after PSA elevation following radical prostatectomy. JAMA1999; 281: 1591. Google Scholar
- 10 : Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA2004; 291: 2441. Google Scholar
- 11 : A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987; 40: 373. Google Scholar
- 12 : Evaluating the yield of medical tests. JAMA1982; 247: 2543. Google Scholar
- 13 : 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA2005; 293: 2095. Google Scholar
- 14 : Short- and long-term mortality with localized prostate cancer. Arch Intern Med2007; 167: 1944. Google Scholar
- 15 : 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol2007; 177: 932. Link, Google Scholar
- 16 : Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy–a propensity scoring approach. J Urol2007; 177: 911. Link, Google Scholar
- 17 : Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol2010; 28: 1508. Google Scholar
- 18 : Pathologic stage migration has slowed in the late PSA era. Urology2007; 70: 839. Google Scholar
- 19 : 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA2004; 292: 821. Google Scholar
- 20 : Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet2002; 360: 103. Google Scholar
- 21 : Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol2003; 13: 450. Google Scholar
- 22 : Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst2006; 98: 355. Google Scholar
- 23 : Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol2009; 191: 956. Google Scholar
- 24 : Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med1999; 341: 1781. Google Scholar
- 25 : Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol2007; 25: 2035. Google Scholar
- 26 : Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol2007; 25: 2420. Google Scholar
- 27 : Cancer incidence after localized therapy for prostate cancer. Cancer2006; 107: 991. Google Scholar
- 28 : Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med2000; 342: 1887. Google Scholar
- 29 : 25-Year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol2006; 176: 569. Link, Google Scholar
